Your browser doesn't support javascript.
loading
Knowledge, Attitudes, and Practices (KAP) Survey on the Safety of Anti-tumor Drugs in Hospital Discharge among Hospital Pharmacist / 中国药学杂志
Chinese Pharmaceutical Journal ; (24): 480-485, 2020.
Article en Zh | WPRIM | ID: wpr-857758
Biblioteca responsable: WPRO
ABSTRACT
OBJECTIVE: To analyze the knowledge, attitude and practice of hospital pharmacists on the safety of patients with anti-tumor drugs discharged from hospitals, explore possible risk factors, and provide reference for targeted guidance and rational medication of tumor patients discharged. METHODS From March 15, 2019 to May 31, 2019, pharmacists at hospitals in 31 provinces (cities) in China conducted a questionnaire survey on the safety of patients with anti-tumor drugs discharged from hospitals. RESULTS: The average score of pharmacists′ knowledges of anti-tumor drugs was 46.7, equivalent to 51.8% of the total score. Most pharmacists (74.5%) are aware of the risks of discharge of antineoplastic agents and are willing (93.9%) to provide medication guidance for cancer patients. However, the pharmacists′ guidance for patients with cancer on the discharge was mostly limited to oral presentation (62.1%), and the accessibility of pharmacists to cancer patients after discharge was generally low (55.6%). CONCLUSION: Drug safety participants pay insufficient attention to the safety risks of patients with anticancer drugs discharged, and hospital pharmacists′ knowledge reserve of anti-tumor drugs has shortcomings, there is no perfect system of medication education for discharged patients, which are all risk factors threatening the safety of medication for cancer patients after discharge. Serious efforts should be made to find solutions to continuously improve the safety of patients with anticancer drugs discharged from hospitals.
Palabras clave
Texto completo: 1 Índice: WPRIM Tipo de estudio: Guideline / Risk_factors_studies Idioma: Zh Revista: Chinese Pharmaceutical Journal Año: 2020 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Tipo de estudio: Guideline / Risk_factors_studies Idioma: Zh Revista: Chinese Pharmaceutical Journal Año: 2020 Tipo del documento: Article